ClinicalTrials.gov record
Recruiting Phase 1Phase 2 Interventional

Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC

ClinicalTrials.gov ID: NCT06681220

Public ClinicalTrials.gov record NCT06681220. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:49 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT06681220
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1, Phase 2
Lead sponsor
VA Office of Research and Development
Federal
Enrollment
166 participants

Conditions and interventions

Interventions

  • Lurbinectedin Drug
  • Stenoparib/Temozolomide Combination Product

Drug · Combination Product

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 22, 2026
Primary completion
Dec 30, 2029
Completion
Dec 30, 2030
Last update posted
Mar 10, 2026

2026 – 2030

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
VA Palo Alto Health Care System, Palo Alto, CA Palo Alto California 94304-1207 Recruiting
Jesse Brown VA Medical Center, Chicago, IL Chicago Illinois 60612 Not yet recruiting
Richard L. Roudebush VA Medical Center, Indianapolis, IN Indianapolis Indiana 46202-2884 Recruiting
Robley Rex VA Medical Center, Louisville, KY Louisville Kentucky 40206-1433 Not yet recruiting
VA Ann Arbor Healthcare System, Ann Arbor, MI Ann Arbor Michigan 48105-2303 Not yet recruiting
Minneapolis VA Health Care System, Minneapolis, MN Minneapolis Minnesota 55417-2309 Not yet recruiting
Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE Omaha Nebraska 68105-1850 Not yet recruiting
Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC Salisbury North Carolina 28144 Recruiting
Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA Philadelphia Pennsylvania 19104-4551 Recruiting
VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA Pittsburgh Pennsylvania 15240 Recruiting
Michael E. DeBakey VA Medical Center, Houston, TX Houston Texas 77030-4211 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06681220, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 10, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06681220 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →